Hosted on Acast. See acast.com/privacy for more information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

my private podcast channel
Hosted on Acast. See acast.com/privacy for more information.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Data visualisation is all the rage, but where does that leave the old-fashioned values of audio? Some data visualisation experts are starting to explore the benefits of turning pictures into sound. Financial Times journalist Alan Smith plays his musical interpretation of a chart depicting the yield-curve of American bonds.
Image: Human heart attack, illustration Credit: Science Photo Library
Justin Amash becomes the first Republican Congressman to say that the President crossed the threshold for impeachment, and Joe Biden says that Democrats don’t want an angry candidate. Congresswoman Pramila Jayapal and Goldie Taylor join Jon, Jon, Tommy, and Dan on stage at the Anthem Theater in Washington, DC.
Dr Joshua Mezrich is a leading transplant surgeon. He tells Andrew Marr how death and life are intimately connected in his field of expertise. And he explains the extraordinary breakthroughs that have emerged in transplant surgery, along with the ethical questions that arise when choosing who will be given the chance of a new beginning. Scientific research needs to be evidence-based. But it can too easily be based on underlying assumptions and biases. The science writer Angela Saini reports on the history - and recent revival - of race science, a field of study that sees race as a biological fact.
Caroline Criado Perez exposes the gender biases in medical and scientific research. She argues that women have often been excluded from the data which has had a huge impact on the efficacy of the pills prescribed, and the treatment offered.
The latest promise of better healthcare is personalised medicine, which aims to get the right dose to the right patient at the right time. But Richard Ashcroft, Professor of Biomedical Ethics, cautions that grouping patients by their genetic constitution may well create new forms of inequality.
Producer: Katy Hickman
Dr Joshua Mezrich is a leading transplant surgeon. He tells Andrew Marr how death and life are intimately connected in his field of expertise. And he explains the extraordinary breakthroughs that have emerged in transplant surgery, along with the ethical questions that arise when choosing who will be given the chance of a new beginning. Scientific research needs to be evidence-based. But it can too easily be based on underlying assumptions and biases. The science writer Angela Saini reports on the history - and recent revival - of race science, a field of study that sees race as a biological fact.
Caroline Criado Perez exposes the gender biases in medical and scientific research. She argues that women have often been excluded from the data which has had a huge impact on the efficacy of the pills prescribed, and the treatment offered.
The latest promise of better healthcare is personalised medicine, which aims to get the right dose to the right patient at the right time. But Richard Ashcroft, Professor of Biomedical Ethics, cautions that grouping patients by their genetic constitution may well create new forms of inequality.
Producer: Katy Hickman
When New York City Mayor Bill de Blasio announced he would run for president, the mockery was swift. City tabloids were typically disdainful (New York Post: “Everyone Hates Bill!”). New York’s attorney general quipped, “Why?” Even de Blasio’s former staffers have declined to voice support for their old boss’s presidential bid. Here, now, an explanation for why New Yorkers are so sure their mayor would be a bad fit for the White House.
Guest: Henry Grabar, Slate staff writer.
Hosted on Acast. See acast.com/privacy for more information.
When New York City Mayor Bill de Blasio announced he would run for president, the mockery was swift. City tabloids were typically disdainful (New York Post: “Everyone Hates Bill!”). New York’s attorney general quipped, “Why?” Even de Blasio’s former staffers have declined to voice support for their old boss’s presidential bid. Here, now, an explanation for why New Yorkers are so sure their mayor would be a bad fit for the White House.
Guest: Henry Grabar, Slate staff writer.
Hosted on Acast. See acast.com/privacy for more information.
When New York City Mayor Bill de Blasio announced he would run for president, the mockery was swift. City tabloids were typically disdainful (New York Post: “Everyone Hates Bill!”). New York’s attorney general quipped, “Why?” Even de Blasio’s former staffers have declined to voice support for their old boss’s presidential bid. Here, now, an explanation for why New Yorkers are so sure their mayor would be a bad fit for the White House.
Guest: Henry Grabar, Slate staff writer.
Learn more about your ad choices. Visit megaphone.fm/adchoices